Smoke, mirrors and Robert Kennedy Jr.’s vaccine safety panel
Don’t let Robert F. Kennedy Jr.’s appointment distract us from fighting the policy changes that could have dire consequences for people with autism.
From funding decisions to scientific fraud, a wide range of societal factors shape autism research.
Don’t let Robert F. Kennedy Jr.’s appointment distract us from fighting the policy changes that could have dire consequences for people with autism.
Apps, robots and brain imaging can help children with autism improve their social skills and connect with other people.
Some women who have children with autism look in the mirror, an accounting firm predicts profit from employees on the spectrum, and 2016 was a slow year for drug approvals.
The jury is still out on autism screening, technology to track wandering children is under attack, and a sensitive Santa Claus sees children on the spectrum.
Autism researchers in the United Kingdom fear that the country’s exit from the European Union will cut funding, scare away talent and strain partnerships.
Immune molecules could be targets for autism treatments, the battle for CRISPR’s patent may be nearing an end, and a plan to give postdoctoral researchers overtime pay is scuttled.
The 21st Century Cures Act, having passed the U.S. Senate, now goes to President Barack Obama, who has promised to sign it.
A sprawling health bill expected to pass the U.S. Senate and become law before the end of the year is a grab bag for industries that spent plenty of money lobbying to make sure it happened that way.
People with autism tend to partner with others on the spectrum, which may raise the condition’s prevalence within families and across the population.
More than 1,455 lobbyists representing 400 companies, universities and other organizations have pushed for or against an earlier House version of the 21st Century Cures bill.